Projects per year
Fingerprint
Dive into the research topics where Susan Lynn Koletar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Pitt-Ohio State Clinical Trials Unit
Riddler, S. (CoPI), Koletar, S. L. (CoPI) & Mellors, J. W. (CoPI)
National Institute of Allergy and Infectious Diseases
12/1/11 → 11/30/26
Project: Research
-
The Ohio State University AIDS Clinical Trials Unit
Koletar, S. L. (PI)
National Institute of Allergy and Infectious Diseases
12/1/11 → 11/30/12
Project: Research
-
LOPINAVIR/RITONAVIR PHARMACOKINETICS IN HIV-1
Koletar, S. L. (PI)
National Center for Research Resources
04/23/07 → 11/30/07
Project: Research
-
SAFETY, TOLERABILITY, AND PHARMACOKINETIC INTERACTIONS OF ATAZANAVIR AND RIFAMP
Koletar, S. L. (PI)
National Center for Research Resources
04/23/07 → 11/30/07
Project: Research
-
The Ohio State University AIDS Clinical Trials Unit
Koletar, S. L. (PI)
National Institute of Allergy and Infectious Diseases
01/18/07 → 11/30/11
Project: Research
-
Effect of hospitalization on cognitive and physical function in people with HIV
Chauhan, L., Wu, K., Tassiopoulos, K., Rubin, L. H., Brown, T. T., Abraham, A., Kasirye, R., Koletar, S., Palella, F. J. & Erlandson, K. M., Sep 2026, In: AIDS. 40, 9, p. 1252-1260 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Glycation metabolites predict incident age-related comorbidities and mortality in older people with HIV
HAILO Study Consortium, Feb 2026, In: GeroScience. 48, 1, p. 379-390 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
W.P.SamanekaWadzanai P.REPRIEVE Investigators, May 2026, In: The Lancet HIV. 13, 5, p. e327-e337Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357
A5357 Study Team, Jan 15 2026, In: Clinical Infectious Diseases. 82, 1, p. 100-108 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
Serum Biomarkers of Macrophage Activation and Incident CKD in People With and Without HIV: Findings From the MACS-WIHS Combined Cohort Study
Fisher, M. C., Hanna, D. B., Hoover, D. R., Shi, Q., Sharma, A., Estrella, M. M., Brown, T. T., Floris-Moore, M., Palella, F. J., Lake, J. E., Kassaye, S. G., Koletar, S. L., Seaberg, E. C., Margolick, J. B., Ofotokun, I., Hickman, A., Augenbraun, M., Fischl, M., Landay, A. L. & Kaplan, R. C. & 1 others, , Apr 2026, In: Open Forum Infectious Diseases. 13, 4Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations